Epidemiology and prevalence of onychomycosis in HIV-positive individuals.
about
Topical and device-based treatments for fungal infections of the toenailsRisk Factors and Comorbidities for Onychomycosis: Implications for Treatment with Topical TherapyNew therapeutic options for onychomycosis.Medical devices for the treatment of onychomycosis.Common nail changes and disorders in older people: Diagnosis and management.Review of antifungal therapy, part II: treatment rationale, including specific patient populations.Spectrum of dermatophyte infections in Botswana.Proximal Subungual Onychomycosis in a Patient with Classic Kaposi Sarcoma Caused by Trichophyton rubrum.British Association of Dermatologists' guidelines for the management of onychomycosis 2014.New pharmacotherapy for the treatment of onychomycosis: an update.Management of Onychomycosis in Canada in 2014.Onychomycosis in children: a brief overview with treatment strategies.Novel investigational therapies for onychomycosis: an update.Patients at risk of onychomycosis--risk factor identification and active prevention.Dermatophytosis: the management of fungal infections.Onychomycosis: beyond cosmetic distress.A preformulation strategy for the selection of penetration enhancers for a transungual formulation.Investigational drugs for onychomycosis.Psychosocial impact of onychomycosis: a review.The prevalence of culture-confirmed toenail onychomycosis in at-risk patient populations.Improving Cure Rates in Onychomycosis.Are Th17 Cells Playing a Role in Immunity to Dermatophytosis?Epidemiology of onychomycosis in Crete, Greece: a 12-year study.Evaluation of improvement of onychomycosis in HIV-infected patients after initiation of combined antiretroviral therapy without antifungal treatment.Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.Clinico-mycological study of dermatophyte toenail onychomycosis in new delhi, India.Cutaneous manifestations of HIV-a detailed study of morphological variants, markers of advanced disease, and the changing spectrumDermatophytosis and immunovirological status of HIV-infected and AIDS patients from Sao Paulo city, Brazil.Onychomycosis in inflammatory bowel diseases.Improvement in onychomycosis after initiation of combined antiretroviral therapy.Fungal nail infections: far more than an aesthetic problem.The prevalence of dermatophyte infection in patients infected with human immunodeficiency virus.Non-dermatophyte mould onychomycosis: a clinical and epidemiological study at a dermatology referral centre in Bogota, Colombia.[Clinical and mycological evaluation of onychomycosis among Brazilian HIV/AIDS patients].Prevalence of xerosis, eczema, and hair and nail abnormalities in PLWHA in Cotonou, Benin.Risk factors associated with onychomycosis.Prevalence and Epidemiology of OnychomycosisFungal infections in immunocompromised patients
P2860
Q24186214-74A48C12-523A-4C0B-AF7D-DE96B2CDB071Q26771955-4FF0EED1-E577-417D-9959-D5CA836A0EAEQ34245375-BFA050D9-A6B5-40B9-BED2-AF0F76E411E4Q34501144-B15E96E0-A10A-4AB1-80AC-06A048D41981Q34573370-DA2CFBF6-7A3E-459E-A350-8BB4C210CF37Q34787956-D027556F-5047-4610-8F89-7B082709D138Q35172498-AC388126-F272-473C-AFF8-1A16D8F7D899Q35422560-82C618A4-9E6A-445E-B5E2-C59BD2B75EB9Q35437556-DF9C2FF1-8C8E-4372-858B-DAF666059D81Q35530025-C3BC43DA-0537-451C-80F9-95E5CD8A403AQ35578703-5C5A73C2-C8D4-4CC5-A03E-90BEA4D4D1FFQ35661102-E913A3E7-CB47-4822-B969-8A7E9BDAE4F0Q35893705-5BA2A247-80B1-4124-9399-A32D015D994EQ36239750-A1228980-D106-45DC-AFB9-3CF0E10975ADQ36311283-A307198B-0CA3-415D-AF5B-E3E06B7AD4E3Q36686125-D88BFF11-DEF7-43D5-82DC-C8CAE85F9A8EQ36882121-25AD478F-685B-4FC9-A8E2-866BEDADC2BDQ38144164-99F7F9BE-4302-4DC1-843D-C989F86A1D56Q38155882-5DBF882C-5611-4BDB-A064-F2ABA25434BDQ38270111-694C8ACE-2CB4-4180-A516-04648E317023Q38867934-85B13D26-0550-41E0-8F0A-9F446A3585B5Q39017758-1F233CC3-20A6-477D-AEE3-CAA068821E54Q40608450-58921E0A-A2FD-4AF9-9F1E-CDBA95B18268Q41117715-7502C597-D7A8-4AA0-8A47-1543DEC5325AQ41189526-18657029-01B6-4350-8C9F-3B85D53B2790Q41378298-A27DCB3B-089D-439E-92B8-A532480B39B7Q42200063-587582C2-6066-41B8-BC1A-D7F74C0A7D02Q42243728-40962779-83A4-47AB-9918-C5D35B7E9432Q44132338-18F60248-4524-4388-AC76-AA9C93545462Q44170598-B47BDEDF-5EDD-4C22-920A-32079EB46445Q44675758-BECC5A22-D30E-4C19-B5E6-9E97EC51E36CQ45396146-8E2E26A5-1A36-4320-932C-7EFEC8602C34Q46038216-357B773A-A24B-4CFD-A80E-F602CF750D47Q46589663-6DB52349-750F-490B-A78D-198C7EE2E011Q46923414-BCB80C25-6F3E-4199-BC82-EB2D9F3FEA0BQ47316585-10001280-B197-47EA-862C-E125A2A814ACQ56533852-F1AB3C46-C233-4437-A3E7-097F640AC7AEQ58404425-ED4FD249-3489-4A1F-8F2B-58CEF4B0A60F
P2860
Epidemiology and prevalence of onychomycosis in HIV-positive individuals.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Epidemiology and prevalence of onychomycosis in HIV-positive individuals.
@ast
Epidemiology and prevalence of onychomycosis in HIV-positive individuals.
@en
type
label
Epidemiology and prevalence of onychomycosis in HIV-positive individuals.
@ast
Epidemiology and prevalence of onychomycosis in HIV-positive individuals.
@en
prefLabel
Epidemiology and prevalence of onychomycosis in HIV-positive individuals.
@ast
Epidemiology and prevalence of onychomycosis in HIV-positive individuals.
@en
P2093
P2860
P1476
Epidemiology and prevalence of onychomycosis in HIV-positive individuals.
@en
P2093
MacDonald P
Summerbell RC
P2860
P304
P356
10.1046/J.1365-4362.2000.00012.X
P577
2000-10-01T00:00:00Z